Blood‐Based Lipid Peroxidation and Ferroptosis‐Related Markers in Friedreich's Ataxia
Movement Disorders · 09.11.2026
DOI: 10.1002/mds.70603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 09.11.2026. Verfasst von Lidia Sarro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Background
Friedreich's ataxia (FRDA) is a neurodegenerative disease caused by reduced levels the mitochondrial frataxin protein. Systemic oxidative stress and iron‐dependent lipid peroxidation, commonly associated with ferroptosis, have a critical role in disease pathogenesis.
Objectives
We aimed to evaluate longitudinal changes of blood‐based indexes of oxidative stress and ferroptosis‐related molecules in adults and children with FRDA.
Methods
We measured plasma levels of 4‐hydroxyl‐2‐nonenals (4‐HNE) and hydroxyeicosatetraenoic acid (15‐HETE), and blood concentration of glutathione (GSH), glutathione disulfide (GSSG), in 62 FRDA patients (48 adults and 14 children) and 63 age matched healthy controls. mRNA levels of major genes targeting the nuclear factor erythroid 2‐related factor 2 (NRF2) were also evaluated. Peripheral concentrations of lipid peroxidation markers and ferroptosis‐related molecules were correlated with age, disease duration, and severity of ataxia signs. Clinical and biochemical evaluations were performed at baseline and at 1‐year follow‐up.
Results
FRDA patients had significantly increased levels of 4‐HNE and GSSG and decreased levels of GSH, compared to controls. Children with FRDA had lower levels of glutathione peroxidase 4 ( GPX4 ) mRNA than adult patients. At 1‐year follow up, plasma 4‐HNE levels remained stable, and blood GPX4 mRNA increased only in adult patient cohort. GPX4 correlated with age, disease duration, and clinical scores.
Conclusions
We provide preliminary evidence of defective GPX4 expression in the early phase of the disease. Our data suggest that GPX4 may represent a biomarker for disease progression and a possible candidate target for therapeutic strategies. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Unit of Muscular and Neurodegenerative Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- University of Milan, Milan, Italy.
ORCID-Profile: Lidia Sarro, Sara Petrillo, Alessia Mongelli, Riccardo Ronco, Anna Castaldo, Andrea Quatrana, Caterina Torda, Federica Loia, Roberta Telese, Enrico Bertini, Fiorella Piemonte, Caterina Mariotti
Förderung
- Ministero della Salute
Zitieren
APA
Sarro, L., Petrillo, S., Mongelli, A., Ronco, R., Castaldo, A., Quatrana, A., Torda, C., Loia, F., Telese, R., Bertini, E., Piemonte, F., & Mariotti, C. (2026). Blood‐Based Lipid Peroxidation and Ferroptosis‐Related Markers in Friedreich's Ataxia. Movement Disorders. https://doi.org/10.1002/mds.70603
Vancouver
Sarro L, Petrillo S, Mongelli A, Ronco R, Castaldo A, Quatrana A, et al. Blood‐Based Lipid Peroxidation and Ferroptosis‐Related Markers in Friedreich's Ataxia. Movement Disorders. 2026. doi:10.1002/mds.70603
BibTeX
@article{Sarro2026,
author = {Sarro, Lidia and Petrillo, Sara and Mongelli, Alessia and Ronco, Riccardo and Castaldo, Anna and Quatrana, Andrea and Torda, Caterina and Loia, Federica and Telese, Roberta and Bertini, Enrico and Piemonte, Fiorella and Mariotti, Caterina},
title = {Blood‐Based Lipid Peroxidation and Ferroptosis‐Related Markers in Friedreich's Ataxia},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70603}
}
EUVIMED